New

High Potency APIs (HPAPI) Market

2021

High Potency APIs (HPAPI) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Generic, Innovative); Type of Synthesis (Synthetic, Biotech); Manufacturer (In-house, Outsourced); Therapeutic Application (Oncology, Hormonal Imbalance, Glaucoma, Others) and Geography

| Report Code: TIPRE00003533 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

High Potency APIs (HPAPI) Market 2028 By Type, Type of Synthesis, Manufacturer, Therapeutic Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



High potency APIs, or HPAPIs, are pharmacologically active ingredients that are extremely effective even in very low doses. The high potency APIs have a very specific action and can provide significant efficacy even at low daily therapeutic doses. They are utilised in the formulation of highly potent medications because of their capacity to target specific disease cells. Small molecules have been used in HPAPIs to provide new patient treatment for respiratory disorders, cancer, and hormonal imbalance. These drugs have minimal adverse effects and target specific locations, allowing the patient to recover faster with no lingering effects.

MARKET SCOPE



The "Global High Potency APIs (HPAPI) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the high potency APIs (HPAPI) market with detailed market segmentation by type, type of synthesis, manufacturer, therapeutic application. The report provides key statistics on the market status of the leading high potency APIs (HPAPI) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on type the market is segmented as, generic and innovative.
  • Based on type of synthesis the market is segmented as, synthetic and biotech.
  • Based on manufacturer the market is bifurcated as, in-house and outsourced.
  • Based on therapeutic application the market is segmented as, oncology, hormonal imbalance, glaucoma and others.

MARKET DYNAMICS


Drivers:



  • Increasing demand for oncological, haematological and hormonal disorder medications.
  • Rising emphasis of pharmaceutical companies on manufacturing of HPAPIs and more precision drugs.
  • Advancements in technologies and extensive R&D efforts to develop HPAPIs and other novel therapies.

Restraints:



  • However, requirement of high initial investment for HPAPI manufacturing along with presence of uncertainity factors with HPAPIs are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The high potency APIs (HPAPI) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the high potency APIs (HPAPI) market in these regions.

IMPACT OF COVID-19 ON HIGH POTENCY APIS (HPAPI) MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. Also due to COVID-19 overall manufacturing and export of high potency APIs get affected as a result of lockdowns and restrictions. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the high potency APIs (HPAPI) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from high potency APIs (HPAPI) market are anticipated to lucrative growth opportunities in the future with the rising demand for high potency APIs (HPAPI) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the high potency APIs (HPAPI) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Pfizer Inc
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • Novartis AG
  • Sanofi
  • Merck Sharp and Dohme Corp
  • Bayer AG
  • AbbVie
  • Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 High Potency APIs (HPAPI) Market - By Type
1.3.2 High Potency APIs (HPAPI) Market - By Type of Synthesis
1.3.3 High Potency APIs (HPAPI) Market - By Manufacturer
1.3.4 High Potency APIs (HPAPI) Market - By Therapeutic Application
1.3.5 High Potency APIs (HPAPI) Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HIGH POTENCY APIS (HPAPI) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. HIGH POTENCY APIS (HPAPI) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HIGH POTENCY APIS (HPAPI) MARKET - GLOBAL MARKET ANALYSIS
6.1. HIGH POTENCY APIS (HPAPI) - GLOBAL MARKET OVERVIEW
6.2. HIGH POTENCY APIS (HPAPI) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. HIGH POTENCY APIS (HPAPI) MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. GENERIC
7.3.1. Overview
7.3.2. Generic Market Forecast and Analysis
7.4. INNOVATIVE
7.4.1. Overview
7.4.2. Innovative Market Forecast and Analysis
8. HIGH POTENCY APIS (HPAPI) MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF SYNTHESIS
8.1. OVERVIEW
8.2. TYPE OF SYNTHESIS MARKET FORECASTS AND ANALYSIS
8.3. SYNTHETIC
8.3.1. Overview
8.3.2. Synthetic Market Forecast and Analysis
8.4. BIOTECH
8.4.1. Overview
8.4.2. Biotech Market Forecast and Analysis
9. HIGH POTENCY APIS (HPAPI) MARKET - REVENUE AND FORECASTS TO 2028 - MANUFACTURER
9.1. OVERVIEW
9.2. MANUFACTURER MARKET FORECASTS AND ANALYSIS
9.3. IN-HOUSE
9.3.1. Overview
9.3.2. In-house Market Forecast and Analysis
9.4. OUTSOURCED
9.4.1. Overview
9.4.2. Outsourced Market Forecast and Analysis
10. HIGH POTENCY APIS (HPAPI) MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC APPLICATION
10.1. OVERVIEW
10.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. ONCOLOGY
10.3.1. Overview
10.3.2. Oncology Market Forecast and Analysis
10.4. HORMONAL IMBALANCE
10.4.1. Overview
10.4.2. Hormonal Imbalance Market Forecast and Analysis
10.5. GLAUCOMA
10.5.1. Overview
10.5.2. Glaucoma Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis

11. HIGH POTENCY APIS (HPAPI) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America High Potency APIs (HPAPI) Market Overview
11.1.2 North America High Potency APIs (HPAPI) Market Forecasts and Analysis
11.1.3 North America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type
11.1.4 North America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type of Synthesis
11.1.5 North America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Manufacturer
11.1.6 North America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Therapeutic Application
11.1.7 North America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Countries
11.1.7.1 United States High Potency APIs (HPAPI) Market
11.1.7.1.1 United States High Potency APIs (HPAPI) Market by Type
11.1.7.1.2 United States High Potency APIs (HPAPI) Market by Type of Synthesis
11.1.7.1.3 United States High Potency APIs (HPAPI) Market by Manufacturer
11.1.7.1.4 United States High Potency APIs (HPAPI) Market by Therapeutic Application
11.1.7.2 Canada High Potency APIs (HPAPI) Market
11.1.7.2.1 Canada High Potency APIs (HPAPI) Market by Type
11.1.7.2.2 Canada High Potency APIs (HPAPI) Market by Type of Synthesis
11.1.7.2.3 Canada High Potency APIs (HPAPI) Market by Manufacturer
11.1.7.2.4 Canada High Potency APIs (HPAPI) Market by Therapeutic Application
11.1.7.3 Mexico High Potency APIs (HPAPI) Market
11.1.7.3.1 Mexico High Potency APIs (HPAPI) Market by Type
11.1.7.3.2 Mexico High Potency APIs (HPAPI) Market by Type of Synthesis
11.1.7.3.3 Mexico High Potency APIs (HPAPI) Market by Manufacturer
11.1.7.3.4 Mexico High Potency APIs (HPAPI) Market by Therapeutic Application
11.2. EUROPE
11.2.1 Europe High Potency APIs (HPAPI) Market Overview
11.2.2 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis
11.2.3 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type
11.2.4 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type of Synthesis
11.2.5 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis - By Manufacturer
11.2.6 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis - By Therapeutic Application
11.2.7 Europe High Potency APIs (HPAPI) Market Forecasts and Analysis - By Countries
11.2.7.1 Germany High Potency APIs (HPAPI) Market
11.2.7.1.1 Germany High Potency APIs (HPAPI) Market by Type
11.2.7.1.2 Germany High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.1.3 Germany High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.1.4 Germany High Potency APIs (HPAPI) Market by Therapeutic Application
11.2.7.2 France High Potency APIs (HPAPI) Market
11.2.7.2.1 France High Potency APIs (HPAPI) Market by Type
11.2.7.2.2 France High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.2.3 France High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.2.4 France High Potency APIs (HPAPI) Market by Therapeutic Application
11.2.7.3 Italy High Potency APIs (HPAPI) Market
11.2.7.3.1 Italy High Potency APIs (HPAPI) Market by Type
11.2.7.3.2 Italy High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.3.3 Italy High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.3.4 Italy High Potency APIs (HPAPI) Market by Therapeutic Application
11.2.7.4 Spain High Potency APIs (HPAPI) Market
11.2.7.4.1 Spain High Potency APIs (HPAPI) Market by Type
11.2.7.4.2 Spain High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.4.3 Spain High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.4.4 Spain High Potency APIs (HPAPI) Market by Therapeutic Application
11.2.7.5 United Kingdom High Potency APIs (HPAPI) Market
11.2.7.5.1 United Kingdom High Potency APIs (HPAPI) Market by Type
11.2.7.5.2 United Kingdom High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.5.3 United Kingdom High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.5.4 United Kingdom High Potency APIs (HPAPI) Market by Therapeutic Application
11.2.7.6 Rest of Europe High Potency APIs (HPAPI) Market
11.2.7.6.1 Rest of Europe High Potency APIs (HPAPI) Market by Type
11.2.7.6.2 Rest of Europe High Potency APIs (HPAPI) Market by Type of Synthesis
11.2.7.6.3 Rest of Europe High Potency APIs (HPAPI) Market by Manufacturer
11.2.7.6.4 Rest of Europe High Potency APIs (HPAPI) Market by Therapeutic Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific High Potency APIs (HPAPI) Market Overview
11.3.2 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis
11.3.3 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type of Synthesis
11.3.5 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis - By Manufacturer
11.3.6 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis - By Therapeutic Application
11.3.7 Asia-Pacific High Potency APIs (HPAPI) Market Forecasts and Analysis - By Countries
11.3.7.1 Australia High Potency APIs (HPAPI) Market
11.3.7.1.1 Australia High Potency APIs (HPAPI) Market by Type
11.3.7.1.2 Australia High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.1.3 Australia High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.1.4 Australia High Potency APIs (HPAPI) Market by Therapeutic Application
11.3.7.2 China High Potency APIs (HPAPI) Market
11.3.7.2.1 China High Potency APIs (HPAPI) Market by Type
11.3.7.2.2 China High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.2.3 China High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.2.4 China High Potency APIs (HPAPI) Market by Therapeutic Application
11.3.7.3 India High Potency APIs (HPAPI) Market
11.3.7.3.1 India High Potency APIs (HPAPI) Market by Type
11.3.7.3.2 India High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.3.3 India High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.3.4 India High Potency APIs (HPAPI) Market by Therapeutic Application
11.3.7.4 Japan High Potency APIs (HPAPI) Market
11.3.7.4.1 Japan High Potency APIs (HPAPI) Market by Type
11.3.7.4.2 Japan High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.4.3 Japan High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.4.4 Japan High Potency APIs (HPAPI) Market by Therapeutic Application
11.3.7.5 South Korea High Potency APIs (HPAPI) Market
11.3.7.5.1 South Korea High Potency APIs (HPAPI) Market by Type
11.3.7.5.2 South Korea High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.5.3 South Korea High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.5.4 South Korea High Potency APIs (HPAPI) Market by Therapeutic Application
11.3.7.6 Rest of Asia-Pacific High Potency APIs (HPAPI) Market
11.3.7.6.1 Rest of Asia-Pacific High Potency APIs (HPAPI) Market by Type
11.3.7.6.2 Rest of Asia-Pacific High Potency APIs (HPAPI) Market by Type of Synthesis
11.3.7.6.3 Rest of Asia-Pacific High Potency APIs (HPAPI) Market by Manufacturer
11.3.7.6.4 Rest of Asia-Pacific High Potency APIs (HPAPI) Market by Therapeutic Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa High Potency APIs (HPAPI) Market Overview
11.4.2 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis
11.4.3 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type of Synthesis
11.4.5 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis - By Manufacturer
11.4.6 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis - By Therapeutic Application
11.4.7 Middle East and Africa High Potency APIs (HPAPI) Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa High Potency APIs (HPAPI) Market
11.4.7.1.1 South Africa High Potency APIs (HPAPI) Market by Type
11.4.7.1.2 South Africa High Potency APIs (HPAPI) Market by Type of Synthesis
11.4.7.1.3 South Africa High Potency APIs (HPAPI) Market by Manufacturer
11.4.7.1.4 South Africa High Potency APIs (HPAPI) Market by Therapeutic Application
11.4.7.2 Saudi Arabia High Potency APIs (HPAPI) Market
11.4.7.2.1 Saudi Arabia High Potency APIs (HPAPI) Market by Type
11.4.7.2.2 Saudi Arabia High Potency APIs (HPAPI) Market by Type of Synthesis
11.4.7.2.3 Saudi Arabia High Potency APIs (HPAPI) Market by Manufacturer
11.4.7.2.4 Saudi Arabia High Potency APIs (HPAPI) Market by Therapeutic Application
11.4.7.3 U.A.E High Potency APIs (HPAPI) Market
11.4.7.3.1 U.A.E High Potency APIs (HPAPI) Market by Type
11.4.7.3.2 U.A.E High Potency APIs (HPAPI) Market by Type of Synthesis
11.4.7.3.3 U.A.E High Potency APIs (HPAPI) Market by Manufacturer
11.4.7.3.4 U.A.E High Potency APIs (HPAPI) Market by Therapeutic Application
11.4.7.4 Rest of Middle East and Africa High Potency APIs (HPAPI) Market
11.4.7.4.1 Rest of Middle East and Africa High Potency APIs (HPAPI) Market by Type
11.4.7.4.2 Rest of Middle East and Africa High Potency APIs (HPAPI) Market by Type of Synthesis
11.4.7.4.3 Rest of Middle East and Africa High Potency APIs (HPAPI) Market by Manufacturer
11.4.7.4.4 Rest of Middle East and Africa High Potency APIs (HPAPI) Market by Therapeutic Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America High Potency APIs (HPAPI) Market Overview
11.5.2 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis
11.5.3 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type
11.5.4 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Type of Synthesis
11.5.5 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Manufacturer
11.5.6 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Therapeutic Application
11.5.7 South and Central America High Potency APIs (HPAPI) Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil High Potency APIs (HPAPI) Market
11.5.7.1.1 Brazil High Potency APIs (HPAPI) Market by Type
11.5.7.1.2 Brazil High Potency APIs (HPAPI) Market by Type of Synthesis
11.5.7.1.3 Brazil High Potency APIs (HPAPI) Market by Manufacturer
11.5.7.1.4 Brazil High Potency APIs (HPAPI) Market by Therapeutic Application
11.5.7.2 Argentina High Potency APIs (HPAPI) Market
11.5.7.2.1 Argentina High Potency APIs (HPAPI) Market by Type
11.5.7.2.2 Argentina High Potency APIs (HPAPI) Market by Type of Synthesis
11.5.7.2.3 Argentina High Potency APIs (HPAPI) Market by Manufacturer
11.5.7.2.4 Argentina High Potency APIs (HPAPI) Market by Therapeutic Application
11.5.7.3 Rest of South and Central America High Potency APIs (HPAPI) Market
11.5.7.3.1 Rest of South and Central America High Potency APIs (HPAPI) Market by Type
11.5.7.3.2 Rest of South and Central America High Potency APIs (HPAPI) Market by Type of Synthesis
11.5.7.3.3 Rest of South and Central America High Potency APIs (HPAPI) Market by Manufacturer
11.5.7.3.4 Rest of South and Central America High Potency APIs (HPAPI) Market by Therapeutic Application

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. HIGH POTENCY APIS (HPAPI) MARKET, KEY COMPANY PROFILES
13.1. PFIZER INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. F HOFFMANN LA ROCHE LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ELI LILLY AND COMPANY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BRISTOL MYERS SQUIBB COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SANOFI
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK SHARP AND DOHME CORP
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABBVIE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Pfizer Inc
- F Hoffmann La Roche Ltd
- Eli Lilly and Company
- Bristol Myers Squibb Company
- Novartis AG
- Sanofi
- Merck Sharp and Dohme Corp
- Bayer AG
- AbbVie
- Teva Pharmaceutical Industries Ltd
- Lonza
- Boehringer Ingelheim International GmbH
- Janssen Pharmaceuticals, Inc
- Dr. Reddy's laboratories
TIPRE00003533
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.